1998
DOI: 10.1016/s0140-6736(05)61119-1
|View full text |Cite
|
Sign up to set email alerts
|

Heterozygote advantage of the MTHFR gene in patients with neural-tube defect and their relatives

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

2
19
0
1

Year Published

1999
1999
2013
2013

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 34 publications
(22 citation statements)
references
References 3 publications
2
19
0
1
Order By: Relevance
“…The most probable explanation for this phenomenon is that the polymorphism represents a heterozygote advantage, one of the known causes of deviation from HWE (together with outbreeding, mutations, gene migration, genetic drift and non-random mating). This is not an isolated phenomenon as it has been previously described and discussed [2][3][4][5][6]. That the A/C genotype might confer a functional advantage is also confirmed by our expression studies.…”
supporting
confidence: 90%
“…The most probable explanation for this phenomenon is that the polymorphism represents a heterozygote advantage, one of the known causes of deviation from HWE (together with outbreeding, mutations, gene migration, genetic drift and non-random mating). This is not an isolated phenomenon as it has been previously described and discussed [2][3][4][5][6]. That the A/C genotype might confer a functional advantage is also confirmed by our expression studies.…”
supporting
confidence: 90%
“…confirm this mutation as a major determinant for NTD (Papapetrou et al 1996;Mornet et al 1997;Speer et al 1997;Boduroglu et al 1998;Koch et al 1998;Weitkamp et al 1998;Shaw et al 1999). The C677T mutation was studied in the Italian population, which has a relatively low prevalence of NTDs.…”
Section: Abstract Neural Tube Defects ·mentioning
confidence: 80%
“…Weitkamp et al 1 reported a heterozygote advantage of the MTHFR gene in patients with neural tube defects (NTD) and their relatives. A C-to-T substitution at nucleotide 677 that converts an alanine to a valine residue in the 5,10-methylenetetrahydofolate-reductase gene (MTHFR) yields a common thermolabile variant (T) with 30% to 50% activity of the allelic form (C).…”
Section: No Evidence For Heterozygote Advantage At Mthfr In Patients mentioning
confidence: 99%
“…Homozygosity for the C677T allele has been shown to be more prevalent in individuals with NTD and their parents, as compared to controls in several studies. [2][3][4][5] Weitkamp et al 1 used a data sample of 168 families with NTD pregnancy (81 anencephaly, 1 encephalocele, and 86 spina bifida). The families were from a variety of ethnic origins consisting of 92.3% Western European, 7.0% Native American, 0.4% African American, and 0.3% Asian.…”
Section: No Evidence For Heterozygote Advantage At Mthfr In Patients mentioning
confidence: 99%